ACAD
Acadia Pharmaceuticals Inc. · Healthcare
CEO Stephen Davis sold $1.8M of Acadia Pharmaceuticals Inc.
Sold$1,792,899
$25.04Price
71,602Shares
−66%Stake
What ACAD did after the filing
- The stock from Fri, Jul 14 open, $30.07
- −4.9%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Aug 25 close.
Traded Tue, Jul 11. Filed Thu, Jul 13, 4:27 PM ET, after the close. Returns use the Jul 14 open and the Aug 25 close. Not investment advice.